{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:25:14Z","timestamp":1783567514673,"version":"3.55.0"},"reference-count":10,"publisher":"Massachusetts Medical Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2025,7,17]]},"DOI":"10.1056\/nejme2504736","type":"journal-article","created":{"date-parts":[[2025,5,18]],"date-time":"2025-05-18T13:40:04Z","timestamp":1747575604000},"page":"303-305","source":"Crossref","is-referenced-by-count":8,"title":["Methotrexate as Initial Therapy for Symptomatic Pulmonary Sarcoidosis?"],"prefix":"10.1056","volume":"393","author":[{"given":"Robert P.","family":"Baughman","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Cincinnati Medical Center, Cincinnati"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse E.","family":"Lower","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Cincinnati Medical Center, Cincinnati"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2024.10.040"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00198-2023"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2017.09.003"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/14799731211031935"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2501443"},{"key":"e_1_3_4_8_2","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial.","volume":"17","author":"Baughman RP","year":"2000","unstructured":"Baughman RP, Winget DB, Lower EE. Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial. Sarcoidosis Vasc Diffuse Lung Dis 2000;17:60-66.10746262","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11071289"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcl038"},{"issue":"3","key":"e_1_3_4_11_2","first-page":"e2020001","article-title":"Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period.","volume":"37","author":"Baughman RP","year":"2020","unstructured":"Baughman RP, Cremers JP, Harmon M, Lower EE, Drent M. Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a large cohort over a six year period. Sarcoidosis Vasc Diffuse Lung Dis 2020;37(3):e2020001-e2020001.33264378","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMe2504736","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T21:00:28Z","timestamp":1752699628000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMe2504736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,7,17]]}},"alternative-id":["10.1056\/NEJMe2504736"],"URL":"https:\/\/doi.org\/10.1056\/nejme2504736","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]}}}